Location History:
- Montebello, NO (2017)
- Oslo, NO (2019 - 2022)
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Else Marit Inderberg Suso
Introduction
Else Marit Inderberg Suso is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of cancer treatment through her innovative patents. With a total of 4 patents, her work focuses on advancing medical technologies that can improve patient outcomes.
Latest Patents
Among her latest patents is a telomerase polypeptide vaccine designed for treating cancer. This polypeptide comprises specific sequences that may have immunogenic fragments, which are crucial for developing effective cancer therapies. Another significant invention is the universal killer T-cell, which involves modified natural killer (NK) cells that are non-immunogenic. These cells can be administered to any recipient without rejection, making them a promising option in personalized medicine, particularly in oncology.
Career Highlights
Else Marit Inderberg Suso has worked with prominent organizations such as Ultimovacs AS and Oslo Universitetssykehus HF. Her experience in these institutions has allowed her to collaborate on groundbreaking research and development projects aimed at enhancing cancer treatment methodologies.
Collaborations
Some of her notable coworkers include Gustav Gaudernack and Anne-Marie Rasmussen, who have contributed to her research endeavors. Their collaboration has been instrumental in advancing the innovations that Suso has developed.
Conclusion
Else Marit Inderberg Suso's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in personalized medicine and cancer therapies.